Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment

Mahmood Barani, Abbas Rahdar, Saman Sargazi, Mohammad Sadegh Amiri, Preetam Sharma, Nikhil Bhalla

Research output: Contribution to journalReview articlepeer-review

43 Citations (Scopus)
210 Downloads (Pure)


Inflammatory bowel disease (IBD) is a group of intestinal disorders which cause prolonged digestive tract inflammation. The early diagnosis of IBD through the detection of its biomarkers (including tumor necrosis factor alpha, C-reactive protein, cytokines and microRNAs) and imaging agents is a challenge. Nanotechnology enabled biosensors and enhanced image contrasting chemicals for diagnosis offer promises for an affordable, early and reliable confirmation of the disease and type thereof. Moreover, engineered nanoparticles (NPs) can also be used to deliver active drug agents directly to the region of inflammation. Major advantages of the targeted drug delivery are low dosage drug requirement due to localized/guided delivery and minimal side effects to other organs by the drug. Here, we present a mini review about different engineered nanostructures (Au NPs, Graphene, Quantum dots, inorganic NPs, etc.) and plant-based nanoparticles for the detection, imaging and treatment of IBD.
Original languageEnglish
Article number100417
JournalSensing and Bio-Sensing Research
Early online date23 Mar 2021
Publication statusPublished (in print/issue) - 30 Jun 2021

Bibliographical note

Publisher Copyright:
© 2021

Copyright 2021 Elsevier B.V., All rights reserved.


  • Inflammatory bowel disease
  • Nanotechnology
  • Diagnosis
  • Biosensors
  • Imaging
  • Drug-delivery


Dive into the research topics of 'Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment'. Together they form a unique fingerprint.

Cite this